Skip to main content

Peer Review reports

From: Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 staining: a multicenter retrospective study

Original Submission
3 May 2021 Submitted Original manuscript
15 May 2021 Reviewed Reviewer Report
13 Jun 2021 Reviewed Reviewer Report
10 Jul 2021 Author responded Author comments - Wenbo Guo
25 Jul 2021 Reviewed Reviewer Report
2 Aug 2021 Reviewed Reviewer Report
26 Aug 2021 Author responded Author comments - Wenbo Guo
Resubmission - Version 2
10 Jul 2021 Submitted Manuscript version 2
18 Sep 2021 Reviewed Reviewer Report
19 Sep 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
5 Oct 2021 Editorially accepted
19 Oct 2021 Article published 10.1186/s12885-021-08858-6

You can find further information about peer review here.

Back to article page